Trigg Leslie 4

What Happened Leslie Trigg, Chair and CEO of Outset Medical, sold 3,361 shares of Common Stock on 2026-02-17 at $3.35 per share, generating proceeds of approximately $11,259. The filing notes this was a "sell-to-cover" transaction to satisfy tax withholding tied to the vesting of previously granted restricted stock units (RSUs), not a discretionary sale.

Key Details

• Transaction date and price: 2026-02-17, sale at $3.35 per share.
• Shares sold: 3,361; proceeds ≈ $11,259.
• Reason/footnote: Sale required to cover partial tax withholding for the vesting of an aggregate 9,319 RSU shares granted on Jan 12, 2024 and Jun 10, 2025 (Footnote F1). Filing states this is not a discretionary trade.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing date and timeliness: Form 4 filed 2026-02-19; appears to be filed within the expected two-business-day window.

Context This was a routine sell-to-cover tied to RSU tax obligations rather than an independent decision to reduce holdings. Such transactions are common when equity awards vest and generally do not signal a change in insider sentiment.